Abstract
Background
A majority of patients with esophageal cancer present with inoperable disease and require rapid and long-lasting palliation of dysphagia.
Study aim
To compare the duration of relief of dysphagia in patients with inoperable esophageal cancer treated with esophageal stenting alone or a combination of esophageal stenting and external beam radiotherapy (EBRT), and to assess overall survival, treatment-related complications, and quality of life (QOL) in the two groups.
Patients and methods
Patients with inoperable esophageal cancer and with high grade dysphagia were randomized to receive esophageal stenting with self-expandable metal stent (Ultraflex) alone (Group I), versus a combination of stenting followed by EBRT (30 gray in ten divided fractions over 2 weeks) (Group II). Dysphagia relief, overall survival, QOL (using European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30, version 3), and treatment-related complications were assessed in the two groups.
Results
From April 2007 to March 2009, 84 patients were randomized to receive esophageal stent alone (42 patients) or a combination of stent and EBRT (42 patients). The two groups were comparable in demographics, tumor characteristics, indications for palliative treatment, and pretreatment dysphagia score. Dysphagia scores improved significantly in both groups following stent insertion. However, dysphagia relief was more sustained in Group II than in Group I (7 vs. 3 months, p = 0.002). Overall median survival was significantly higher in Group II than in Group I (180 vs. 120 days, p = 0.009). Addition of radiotherapy following stenting prolonged the mean dysphagia-free survival (118.6 ± 55.8 vs. 96.8 ± 43.0 days, p = 0.054). There was significant improvement in all QOL parameters at 1 week after stenting. The QOL, however, significantly declined immediately after radiotherapy. There was no treatment-related mortality, and the incidence of complications was similar in the two groups.
Conclusion
Post-stenting EBRT effectively prolongs duration of dysphagia relief and improves overall survival in inoperable esophageal cancer.
Similar content being viewed by others
References
Sreedharan A, Harris K, Crellin A, Forman D, Everett SM. Interventions for dysphagia in esophageal cancer. Cochrane Database Syst Rev. 2009;(4):CD005048.
Watkinson AF, Ellul J, Entwinsle K, Mason RC, Adam A. Esophageal carcinoma: initial results of palliative treatment with covered self-expanding endoprostheses. Radiology. 1995;195:821–7.
Bown SG. Palliation of malignant dysphagia: surgery, radiotherapy, laser, intubation alone or in combination? Gut. 1991;32(8):841–4.
Ogilvie AL, Dronfield MW, Ferguson R, Atkinson M. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut. 1982;23(12):1060–7.
Song HY, Lee DH, Seo TS, et al. Retrievable covered nitinol stents: experiences in 108 patients with malignant esophageal strictures. J Vasc Interv Radiol. 2002;13(3):285–93.
Zhong J, Wu Y, Xu Z, Liu X, Xu B, Zhai Z. Treatment of medium and late stage esophageal carcinoma with combined endoscopic metal stenting and radiotherapy. Chin Med J. 2003;116(1):24–8.
Han YT, Peng L, Fang Q, Li Q. Value of radiotherapy and chemotherapy after SEMS implantation operation in patients with malignant esophageal stricture. Ai Zheng. 2004;23(6):682–4.
Yu YT, Yang G, Liu Y, et al. Clinical evaluation of radiotherapy for advanced esophageal cancer after metallic stent placement. World J Gastroenterol. 2004;10(14):2145–6.
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.
Mellow MH, Pinkas H. Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction: analysis of technical and functional efficacy. Arch Intern Med. 1995;145:1443–6.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.
Dua KS. Stents for palliating malignant dysphagia and fistula: is the paradigm shifting? Gastrointest Endosc. 2007;65(1):77–81.
Homann N, Noftz MR, Klingenberg-Noftz RD, Ludwig D. Delayed complications after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate. Dig Dis Sci. 2008;53(2):334–40.
Pearson JG. The present status and future potential of radiotherapy in the management of esophageal cancer. In: Silber F, editor. Carcinoma of the esophagus. Cancer 1977;39(2 Suppl):882–90.
Siersema PD, Hop WC, van Blankenstein M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective randomized study. Gastrointest Endosc. 2001;54(2):145–53.
Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from esophageal cancer: multicentre randomized trial. Lancet. 2004;364(9444):1497–504.
Conio M, Repici A, Battaglia G, et al. A randomized prospective comparison of self-expanding plastic stents and partially covered self-expanding metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol. 2007;102(12):2667–77.
Ludwig D, Dehne A, Burmester E, et al. Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy. Int J Oncol. 1998;13(3):583–8.
Schmid EU, Alberts AS, Greeff F, et al. The value of radiotherapy or chemotherapy after intubation for advanced esophageal carcinoma—a prospective randomized trial. Radiother Oncol. 1993;28(1):27–30.
Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20(5):1167–74.
Alberts AS, Burger W, Greeff F, et al. Severe complications of 5-fluorouracil and cisplatin with concomitant radiotherapy in inoperable non-metastatic squamous cell oesophageal cancer after intubation—early termination of a prospective randomised trial. Eur J Cancer. 1992;28:1005–6.
Nishimura Y, Nagata K, Katano S, et al. Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal Diseases. Int J Radiat Oncol Biol Phys. 2003;56:1327–32.
O’Hanlon DM, Callanan K, Karat D, et al. Outcome, survival, and costs in patients undergoing intubation for carcinoma of the esophagus. Am J Surg. 1997;174(3):316–9.
Madhusudan C, Saluja SS, Pal S, et al. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus. 2009;22(4):331–6.
Maroju NK, Anbalagan P, Kate V, et al. Improvement in dysphagia and quality of life with self-expanding metallic stents in malignant esophageal strictures. Indian J Gastroenterol. 2006;25(2):62–5.
Acknowledgments
This study was supported by All India Institute of Medical Sciences, New Delhi, India. No financial grants or other funding was received for this study. None of the authors has any industrial links or affiliations. No other colleagues or institutes apart from the authors have contributed to the study.
Source of funding for research and publication
All India Institute of Medical Sciences, New Delhi, India.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Javed, A., Pal, S., Dash, N.R. et al. Palliative Stenting With or Without Radiotherapy for Inoperable Esophageal Carcinoma: A Randomized Trial. J Gastrointest Canc 43, 63–69 (2012). https://doi.org/10.1007/s12029-010-9206-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-010-9206-4